State-of-the-art paperThe quantification of infarct size
Under an Elsevier user license
open archive
Abbreviations and acronyms
CK
creatine kinase
CK-MB
creatine kinase-MB fraction
HBDH
hydroxybutyrate dehydrogenase
MI
myocardial infarction
MRI
magnetic resonance imaging
SPECT
single-photon emission computed tomography
Tc
technetium
Cited by (0)
Dr. Gibbons has received research grants from Medtronic, King Pharm, Wyeth-Ayerst, Radiant Medical, Alsius Corp., Ther Ox, Innercool Therapies, Boston Scientific, Spectranectics, KAI Pharmaceuticals, and Boehringer Ingelheim and is a consultant for CV Therapeutics, DOV Pharmaceuticals, King Pharm, Medicure, Hawaii Biotech, Glaxo Smith Kline, Molecular Insight Pharm, Ther Ox, and TargeGen. Dr. Jaffe’s potential conflicts include Roche, Dade-Behring, and Beckman Coulter (consulting and research funds) and Pfizer, Abbott, and Sensera (consulting).
Copyright © 2004 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.